Treatment of neovascular glaucoma after proton therapy for uveal melanomas with ranibizumab injection: Preliminary results

Ophthalmic Research

Volumn 47, Issue 2, 2012, Pages 57-60

  Caujolle, Jean Pierre ^a   Maschi, Celia ^a   Freton, Aurelien ^a   Pages, Gilles ^b   Gastaud, Pierre ^a  

^a University Hospital of Nice University of Nice Sophia Antipolis   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Neovascular glaucoma; Proton therapy; Ranibizumab; Uveal melanoma

Indexed keywords

ACETAZOLAMIDE; RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CRYOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; PROTON THERAPY; RETINA DETACHMENT; RETROSPECTIVE STUDY; TRABECULECTOMY; UVEA MELANOMA; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MELANOMA; MIDDLE AGED; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; UVEAL NEOPLASMS; VISUAL ACUITY;

EID: 79959677918     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000328633     Document Type: Article

References (10)

1. Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P: Proton beam radiotherapy for uveal melanomas at Nice Teaching Hospital: 16 years' experience. Int J Radiat Oncol Biol Phys 2010;78:98-103.
2. Gragoudas ES: Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld lecture. Invest Ophthalmol Vis Sci 2006;47:4666-4673.
3. Boyd SR, Gittos A, Richter M, Hungerford JL, Errington RD, Cree IA: Proton beam therapy and iris neovascularisation in uveal melanoma. Eye 2006;20:832-836.
4. Foss AJ, Whelehan I, Hungerford JL, Anderson DF, Errington RD, Kacperek A, Restori M, Kongerud J, Sheen M: Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 1997;81:748-754.
5. Boyd SR, Tan D, Bunce C, Gittos A, Neale MH, Hungerford JL, et al: Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol 2002;86:448-452.
6. Missotten GS, Notting IC, Schlingemann RO, Zijlmans HJ, Lau C, Eilers PH, Keunen JE, Jager MJ: Vascular endothelial growth factor A in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428-1434.
7. Jager MJ: Angiogenesis in uveal melanoma. Ophthalmic Res 2006;38:248-250.
8. Dunavoelgyi R, Zehetmayer M, Simader C, Schmidt-Erfurth U: Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection. Clin Experiment Ophthalmol 2007;35:878-880.
9. Vásquez LM, Somani S, Altomare F, Simpson ER: Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma. Can J Ophthalmol 2009;44:106-107.
10. Hirasawa N, Tsuji H, Ishikawa H, Koyama-Ito H, Kamada T, Mizoe JE, Ito Y, Naganawa S, Ohnishi Y, Tsujii H: Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dosevolume histogram analysis. Int J Radiat Oncol Biol Phys 2007;67:538-543.